COVID-19 diagnosis or suspected diagnosis: prohibited actions by insurers, pharmacy benefit managers, and self-insured health plans [Sec. 13, 14, 20, 75, 78, 91, 93-95] - SB932

Dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis to patient with end-stage renal disease: exemption from pharmacist license requirement, conditions set [S.Amdt.1: remove comma from ``dialysate, drugs"] - SB38

Dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis to patient with end-stage renal disease: exemption from pharmacist license requirement, conditions set - AB42

Epinephrine for ambulances purchased and provided by DHS; authority of pharmacist re therapeutic interchange for drugs prescribed to counteract anaphylaxis - AB1011

Health care provider credentials issued by DSPS: exemption from renewal during the 2020 public health emergency; former health care providers may obtain temporary credentials under certain conditions; fee provision [Sec. 86, 105 (4), (5)] - SB932

Health care provider credentials issued by DSPS: exemption from renewal during the 2020 public health emergency; former health care providers may obtain temporary credentials under certain conditions; fee provision [Sec. 86, 105 (4), (5)] [A.Amdt.4: temporary credentials for former health care providers provision revised, health care facility and malpractice insurance provisions added] - AB1038

Health care providers from another state: temporary credentials from DSPS that expire 90 days after the conclusion of the 2020 public health emergency, fee provision [Sec. 105 (6), (7)] - SB932

Health care providers from another state: temporary credentials from DSPS that expire 90 days after the conclusion of the 2020 public health emergency, fee provision [Sec. 105 (6), (7)] [A.Amdt.4: further revisions, health care facility and medical malpractice provisions added, fee provision removed] - AB1038

Pharmacists authorized to extend a prescription order during the 2020 public health emergency under certain conditions [Sec. 87, 88] - AB1038

Pharmacists authorized to extend a prescription order during the 2020 public health emergency under certain conditions [Sec. 87, 88] - SB932

Pharmacists permitted to prescribe, administer, and dispense injectable and self-administered hormonal contraceptives; Pharmacy Examining Board and emergency rules provisions - AB290

Pharmacists permitted to prescribe contraceptives to persons at least 18 years of age; Pharmacy Examining Board and emergency rules provisions - AB304

Pharmacists permitted to prescribe contraceptives to persons at least 18 years of age; Pharmacy Examining Board and emergency rules provisions - SB286

Pharmacy benefit manager regulation and registration with OCI established; audits of pharmacists or pharmacies requirements; insurance policy cannot restrict or penalize pharmacy for informing insured of price differences of prescribed drug or device; drug substitution, cost sharing limitation, and choice of provider provisions - AB114

Pharmacy benefit manager regulation and registration with OCI established; audits of pharmacists or pharmacies requirements; insurance policy cannot restrict or penalize pharmacy for informing insured of price differences of prescribed drug or device; drug substitution, cost sharing limitation, and choice of provider provisions - SB100

Pharmacy license required for jails, correctional or residential facilities, and health care facilities, provider offices or clinics that have a pharmacist; remote dispensing site provisions revised - SB738

Pharmacy license required for jails, correctional or residential facilities, and health care facilities, provider offices or clinics that have a pharmacist; remote dispensing site provisions revised - AB788

Pharmacy technicians: registration with Pharmacy Examining Board required; emergency rules provision - AB847

Pharmacy technicians: registration with Pharmacy Examining Board required; emergency rules provision - SB778

Prescription drug cost disclosure requirements for drug manufacturers and health insurers; reports and OCI duties - AB62

Prescription drug cost reporting by drug manufacturers, insurers, and hospitals; pharmacy benefit managers drug cost report and registration requirements; insurance policy cannot restrict or penalize pharmacy for informing insured of price differences of a drug or biological product [Sec. 2093-2095, 9123 (1)] - SB59

Prescription drug cost reporting by drug manufacturers, insurers, and hospitals; pharmacy benefit managers drug cost report and registration requirements; insurance policy cannot restrict or penalize pharmacy for informing insured of price differences of a drug or biological product [Sec. 2093-2095, 9123 (1); original bill only] - AB56

Prescription drug limits: health insurance policy or pharmacy benefit manager prohibited from imposing during the 2020 public health emergency, exception for controlled substances [Sec. 90, 97] - AB1038

Prescription drug limits: health insurance policy or pharmacy benefit manager prohibited from imposing during the 2020 public health emergency, exception for controlled substances [Sec. 90, 97] - SB932

Prescription drug payments: disability insurance policy required to apply to out-of-pocket maximum or other cost-sharing requirement - SB907

Prescription drug pooling: DETF to study options and cost savings to state agencies, report required [Sec. 9113 (3)] - SB59

Prescription drug pooling: DETF to study options and cost savings to state agencies, report required [Sec. 9113 (3); original bill only] - AB56

Step therapy protocols for prescription drug coverage established - AB24

Step therapy protocols for prescription drug coverage established [S.Sub.Amdt.1: further revisions] - SB26